The mRNA technology faces growing doubts among Republicans, including people around President Donald Trump. Legislation aimed ...

Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...

Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...

HHS is re-evaluating a nearly $600 million contract with Moderna to develop and test vaccines against flu viruses that could ...

Now the nation’s top health official, Kennedy is reevaluating the US Health and Human Services’s contract with Moderna, which ...

Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...

The surge in MRNA stock comes after some SEC filings show that company insiders bought shares worth $6 million.

Shares of the American pharmaceutical company Moderna (MRNA) climbed over 8% in pre-market trading following strategic ...

Highly pathogenic avian influenza continues to devastate poultry flocks throughout the United States, as well as cause ...

mRNA cancer vaccines work by giving the body instructions ... of Covid vaccines was starting to close down, but companies like Moderna and BioNTech were trying to figure out what to do next ...

Vaccine manufacturers would have to waive indemnity from lawsuits for injuries stemming from vaccines under a bill advancing in the Iowa Senate. Sen. Doug Campbell, R-Mason City, at a subcommittee ...

But those calling for a ban on all mRNA vaccines say there is a dearth of long-term safety data, and they say covid vaccines by Pfizer-BioNTech and Moderna were hastily approved without proper ...